Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis

Jorge Labrador, MD, Oriana López-Godino, Lucía López-Corral, MD, Estefanía Pérez-López, MD, Mónica Cabrero-Calvo, MD, Roberto Pérez-López, José María Bastida, Miriam López-Parra, Ignacio Alberca, PhD, José Ramón González-Porras, PhD, Dolores Caballero, MD

Blood (2012) 120 (21): 1955.

https://doi.org/10.1182/blood.V120.21.1955.1955

Published: 2012

Journal Articles

The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Pere Barba, David Valcarcel, MD, Lucía López-Corral, MD, Francesc fernandez-Aviles, Rodrigo Martino, MD, PhD, Monica Cabrero, Montserrat Rovira, jose Luis Pinana, Salut Brunet, Enric Carreras, MD, PhD, maria Dolores Caballero, Jorge Sierra, MD

Blood (2012) 120 (21): 1925.

https://doi.org/10.1182/blood.V120.21.1925.1925

Published: 2012

Journal Articles

Intra-Clonal Heterogeneity Is a Critical Early Event in the Preclinical Stages of Multiple Myeloma and Is Subject to Darwinian Fluctuation throughout the Disease

Lorenzo Melchor, PhD, Brian A Walker, BSc, PhD, Christopher P Wardell, PhD, Annamaria Brioli, MD, Martin F Kaiser, MD, Lucía López-Corral, MD, Sean Humphray, Lisa Murray, Mark Ross, David Bentley, Ramón García-Sanz, Jesús F San Miguel, MD, PhD, Faith E. Davies, MD, David Gonzalez, PhD, Gareth J. Morgan, MD PhD

Blood (2012) 120 (21): 3941.

https://doi.org/10.1182/blood.V120.21.3941.3941

Published: 2012

Journal Articles

Transcriptome Analysis Reveals Molecular Profiles Associated with Evolving Steps of Monoclonal Gammopathies.

Lucía López Corral, Luis Antonio Corchete, Maria Victoria Mateos, MD, PhD, Ramon Garcia-Sanz, Encarna Fermiñán, Juan José Lahuerta, Joan Blade, MD, Albert Oriol, Ana Isabel Teruel, Maria Luz Martino, MD, Jose Hernández, Jesús M Hernández-Rivas, Jesus F San Miguel, Norma Gutierrez

Blood (2012) 120 (21): 2914.

https://doi.org/10.1182/blood.V120.21.2914.2914

Published: 2012

Journal Articles

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

Jose Antonio Perez-Simón, Sr., MD, PhD, Rodrigo Martino, MD, PhD, Rocio Parody, MD, M. Cabrero, Lucía López-Corral, David Valcarcel, MD, Carmen Martinez, MD, Carlos Solano, Rafael De La Camara, MD, Inmaculada Heras, Dolores Caballero, MD, Jordi Sierra, MD, PhD

Blood (2011) 118 (21): 890.

https://doi.org/10.1182/blood.V118.21.890.890

Published: 2011

Journal Articles

Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

Blood (2011) 118 (21): 991.

https://doi.org/10.1182/blood.V118.21.991.991

Published: 2011

Journal Articles

Myelodysplasia-Associated Immunophenotypic Abnormalities of Bone Marrow (BM) Cells in Multiple Myeloma (MM): Are They Present At Diagnosis or Can Be Induced by Lenalidomide?

Sergio Matarraz, Bruno Paiva, Maria Victoria Mateos, María Diez-Campelo, MD, PhD, Estefania Perez, María-Belén Vidriales, Lucía López-Corral, Pilar Giraldo, Miguel T. Hernandez, Felipe de Arriba, Javier De La Rubia, Joan Bargay, Fernando Leal da Costa, Graça Esteves, Juan José Lahuerta, Laura Rosiñol, MD, Joan Blade, Jesus F. San Miguel, MD, PhD, Alberto Orfao, MD, PhD

Blood (2011) 118 (21): 5066.

https://doi.org/10.1182/blood.V118.21.5066.5066

Published: 2011

Journal Articles

SNP-Based Mapping Arrays Reveal High Genomic Complexity in Monoclonal Gammopathies: From the MGUS to Myeloma Status

Lucía López-Corral, Maria Eugenia Sarasquete, Sílvia Beà, Ramón García-Sanz, Maria Victoria Mateos, Marcos González, MD, Luis Antonio Corchete, Joan Bladé, MD, Albert Oriol-Rocafiguera, Miguel Hernandez, Pilar Giraldo, Jose Hernández, Jesús M Hernández-Rivas, Jesús F San Miguel, Norma C. Gutierrez

Blood (2011) 118 (21): 295.

https://doi.org/10.1182/blood.V118.21.295.295

Published: 2011

Journal Articles

Whole Genome Sequencing Illuminates the Genetic and Biological Features Underlying the Transition of SMM to MM

Brian A Walker, PhD, Christopher P Wardell, PhD, Lucía López-Corral, Sean Humphray, Lisa Murray, Mark Ross, Ramón García-Sanz, David Bentley, Jesús F San Miguel, David Gonzalez, PhD, Gareth J Morgan, MD PhD

Blood (2011) 118 (21): 296.

https://doi.org/10.1182/blood.V118.21.296.296

Published: 2011

Journal Articles

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,

Blood (2011) 118 (21): 3936.

https://doi.org/10.1182/blood.V118.21.3936.3936

Published: 2011

Journal Articles

Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients,

Bruno Paiva, Maria Victoria Mateos, Lucía López-Corral, María-Belén Vidriales, Miguel T. Hernandez, Joan Bargay, Felipe de Arriba, Javier De La Rubia, Ana-Isabel Teruel, Pilar Giraldo, Laura Rosiñol, MD, Felipe Prosper, MD, Albert Oriol, Jose Hernández, Graça Esteves, Fernando Leal da Costa, Juan José Lahuerta, Joan Blade, Jesus F. San Miguel, MD, PhD

Blood (2011) 118 (21): 3944.

https://doi.org/10.1182/blood.V118.21.3944.3944

Published: 2011

Journal Articles

Competition Between (Mono)Clonal Plasma Cells and Normal Cells for Potentially Overlapping Bone Marrow Niches Is Associated with a Progressively Altered Cellular Distribution In MGUS Vs. Myeloma

Blood (2010) 116 (21): 617.

https://doi.org/10.1182/blood.V116.21.617.617

Published: 2010

Journal Articles

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Bruno Paiva, Lucía López-Corral, María-Belén Vidriales, Luis Ignacio Sánchez Abarca, Miguel T. Hernandez, Joan Bargay, Javier De La Rubia, Pilar Giraldo, Ana-Isabel Teruel, Laura Rosiñol, Albert Oriol, Jose Hernández, Felipe de Arriba, Graça Esteves, Jose Antonio Pérez Simón, María-Victoria Mateos, Jesus F San Miguel

Blood (2010) 116 (21): 1906.

https://doi.org/10.1182/blood.V116.21.1906.1906

Published: 2010

Journal Articles

Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

Blood (2010) 116 (21): 1935.

https://doi.org/10.1182/blood.V116.21.1935.1935

Published: 2010

Journal Articles

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

Blood (2009) 114 (22): 614.

https://doi.org/10.1182/blood.V114.22.614.614

Published: 2009

Journal Articles

DNA Double Strand Breaks Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

Enrique M Ocio, Patricia Maiso, Xi Chen, Mercedes Garayoa, Stela Álvarez-Fernández, Laura San-Segundo, David Vilanova, Lucía López-Corral, Juan Carlos Montero, Teresa Hernández-Iglesias, Enrique de Álava, Carlos Galmarini, Pablo Avilés, Carmen Cuevas, Atanasio Pandiella, J.F. San Miguel, MD, PhD

Blood (2008) 112 (11): 245.

https://doi.org/10.1182/blood.V112.11.245.245

Published: 2008

NARROW

Severe Gut Acute Graft Versus host Disease (GVHD) Influence Thrombotic Microangiopathy in 86 Allogeneic Hematopoietic Stem Cell Recipients Who Received Tacrolimus-Based Regimen for GVHD Prophylaxis

The Combination of the EBMT Score and the HCT-CI Is Not Better Than the HCT-CI Alone in the Prediction of NRM and OS in Patients Undergoing Allogeneic Hematopoietic Transplantation with Reduced-Toxicity Conditioning

Intra-Clonal Heterogeneity Is a Critical Early Event in the Preclinical Stages of Multiple Myeloma and Is Subject to Darwinian Fluctuation throughout the Disease

Transcriptome Analysis Reveals Molecular Profiles Associated with Evolving Steps of Monoclonal Gammopathies.

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

Smoldering Multiple Myeloma (SMM) At High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) As Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

Myelodysplasia-Associated Immunophenotypic Abnormalities of Bone Marrow (BM) Cells in Multiple Myeloma (MM): Are They Present At Diagnosis or Can Be Induced by Lenalidomide?

SNP-Based Mapping Arrays Reveal High Genomic Complexity in Monoclonal Gammopathies: From the MGUS to Myeloma Status

Whole Genome Sequencing Illuminates the Genetic and Biological Features Underlying the Transition of SMM to MM

Biological and Clinical Significance of CD81 Expression by Clonal Plasma Cells in High-Risk Smoldering and Symptomatic Multiple Myeloma (MM) Patients,

Influence of Lenalidomide Treatment on Immune Effector Cells From High-Risk Smoldering Multiple Myeloma (SMM) Patients,

Competition Between (Mono)Clonal Plasma Cells and Normal Cells for Potentially Overlapping Bone Marrow Niches Is Associated with a Progressively Altered Cellular Distribution In MGUS Vs. Myeloma

Multiparameter Flow Cytometry Analysis of Peripheral Blood T, NK and Dendritic Cells From High-Risk Smoldering Multiple Myeloma Patients Treated with Lenalidomide and Dexamethasone

Smoldering Multiple Myeloma (SMM) at High-Risk of Progression to Symptomatic Disease: A Phase III, Randomized, Multicenter Trial Based On Lenalidomide-Dexamethasone (Len-Dex) as Induction Therapy Followed by Maintenance Therapy with Len Alone Vs No Treatment

Multicenter, Randomized, Open-Label, Phase III Trial of Lenalidomide-Dexamethasone (Len/dex) Vs Therapeutic Abstention in Smoldering Multiple Myeloma at High Risk of Progression to Symptomatic MM: Results of the First Interim Analysis.

DNA Double Strand Breaks Induction by Zalypsis, a Novel Marine Compound, Results in Potent Antimyeloma Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only